Used as a key intermediate in the synthesis of pharmaceutical compounds, particularly in the development of active pharmaceutical ingredients (APIs) where a protected amine on a cyclohexyl scaffold is required. Its structure allows for selective functionalization in multi-step syntheses, making it valuable in creating drug candidates targeting central nervous system disorders, metabolic diseases, and inflammatory conditions. The tert-butyl carbamate (Boc) group provides stability during reactions and can be easily removed under mild acidic conditions, enabling efficient deprotection without damaging sensitive functional groups elsewhere in the molecule. Commonly employed in combinatorial chemistry and medicinal chemistry research for building nitrogen-containing heterocycles and constrained amine derivatives.